Home

We partner with early stage ventures to build companies that transform lives and industries.

About Us

Since 1962, Elron has been at the forefront of Israeli innovation, as founders and early investors in companies such as Elbit Systems, Elscint, Zoran, Partner, Netvision and Given Imaging.

Today we remain committed to our vision of identifying transformative technologies, nurturing gifted entrepreneurs, and building companies into technology leaders.

Our team is dedicated to attracting and supporting imaginative and focused entrepreneurs and startups with never-been-done-before ideas. Group companies benefit from our combined technological, strategic, entrepreneurial & business expertise, broad networks, and wide attention span.

A word from our founder

Where We Invest

We invest in treatment-changing (rather than treatment-enhancing) medical device companies. We seek companies with billion-$ market potential. We usually invest in the idea/R&D stage.
We invest in exceptional ideas and technologies with the potential to transform or create new markets, and help make the world a more secure place to live in. We seek investment opportunities from seed to growth stages.

RDC

Strategic JV

RDC was founded in 1993 by Elron and Rafael, a global leader of defense technologies and one of Israel's largest defense companies. RDC combines Rafael's scale and technological edge, with Elron's vast expertise in helping startups develop into leading tech companies.

Through RDC, which has exclusive rights to commercialize Rafael's defense technologies in civilian markets, we initiate and develop new companies, and provide essential support from start to exit.

Since its inception, RDC has successfully invested in numerous hi-tech companies. A prime example of RDC's active end-to-end involvement in the growth of its companies is Given Imaging. Given Imaging redefined gastrointestinal disease diagnosis by developing the PillCam ingestible video capsule, based on a unique technology initially invented for military purposes. After becoming a world leader in its field, Given Imaging was acquired for $1 billion.

How We Invest

We aim high.

We invest primarily in early stage ventures with significant exit potential, in which we seek significant shareholder stakes, enabling us to provide hands-on support and contribute from our experience.

We become involved.

We play a defining role in the development of our group companies, by means of active involvement in all aspects of their business and day-to-day operations, to help them reach their long-term objectives.

We are committed.

As an operational holding company that invests its own capital in new and existing group companies, we have the flexibility to support the growth of our group companies over the long term, weather setbacks, and maximize exit events.

Key Stats

$1.5b

value of exit transactions since 2010

$246m

investments since 2010

$140m

dividends distributed since 2010

12

M&As since 2010

$188m

total amount invested in current group companies

News

More news

OpenLegacy and Compuware Partner to Help Customers Speed Mainframe-to-Modern-App Software Development with Cloud-Native Approach

October 1, 2019

OpenLegacy’s platform, now accessed directly from Compuware Topaz® Workbench, enables rapid automated creation of mainframe APIs for large enterprises

Read More

Cynerio honored as Gold winner in the 11th Annual 2019 Golden Bridge Awards® in the Medical Information Security Category

September 29, 2019

More than 160 judges from a broad spectrum of industry voices from around the world participated and determined the 2019 Golden Bridge Awards Finalists and Winners

Read More

Hello, ZenGo 2.0!

September 24, 2019

This version is just the beginning of bigger plans KZen has for ZenGo on its mission to provide the easiest, most convenient and secure wallet on the planet

Read More
More news